Literature DB >> 16810401

History of cannabis as a medicine: a review.

Antonio Waldo Zuardi1.   

Abstract

Cannabis as a medicine was used before the Christian era in Asia, mainly in India. The introduction of cannabis in the Western medicine occurred in the midst of the 19th century, reaching the climax in the last decade of that century, with the availability and usage of cannabis extracts or tinctures. In the first decades of the 20th century, the Western medical use of cannabis significantly decreased largely due to difficulties to obtain consistent results from batches of plant material of different potencies. The identification of the chemical structure of cannabis components and the possibility of obtaining its pure constituents were related to a significant increase in scientific interest in such plant, since 1965. This interest was renewed in the 1990's with the description of cannabinoid receptors and the identification of an endogenous cannabinoid system in the brain. A new and more consistent cycle of the use of cannabis derivatives as medication begins, since treatment effectiveness and safety started to be scientifically proven.

Mesh:

Substances:

Year:  2006        PMID: 16810401     DOI: 10.1590/s1516-44462006000200015

Source DB:  PubMed          Journal:  Braz J Psychiatry        ISSN: 1516-4446            Impact factor:   2.697


  96 in total

Review 1.  Cannabinoid modulation of noradrenergic circuits: implications for psychiatric disorders.

Authors:  Ana Franky Carvalho; Elisabeth J Van Bockstaele
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-01-24       Impact factor: 5.067

Review 2.  Blurred boundaries: the therapeutics and politics of medical marijuana.

Authors:  J Michael Bostwick
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

3.  Use of Cannabis to Relieve Pain and Promote Sleep by Customers at an Adult Use Dispensary.

Authors:  Marcus Bachhuber; Julia H Arnsten; Gwen Wurm
Journal:  J Psychoactive Drugs       Date:  2019-07-02

4.  "K2/Spice": have you updated your differentials? A case report.

Authors:  Roopa Sethi; Neha Thapa; Ashwini Saxena; Ritu Chahil
Journal:  Prim Care Companion CNS Disord       Date:  2013

Review 5.  The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products.

Authors:  Lisa K Brents; Paul L Prather
Journal:  Drug Metab Rev       Date:  2013-09-24       Impact factor: 4.518

6.  No evidence for reduction of opioid-withdrawal symptoms by cannabis smoking during a methadone dose taper.

Authors:  David H Epstein; Kenzie L Preston
Journal:  Am J Addict       Date:  2015-04-06

7.  Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors.

Authors:  Maheswari Rajasekaran; Lisa K Brents; Lirit N Franks; Jeffery H Moran; Paul L Prather
Journal:  Toxicol Appl Pharmacol       Date:  2013-03-26       Impact factor: 4.219

Review 8.  Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe?

Authors:  Shokouh Arjmand; Zohreh Vaziri; Mina Behzadi; Hassan Abbassian; Gary J Stephens; Mohammad Shabani
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

9.  Functional role of cannabinoid receptors in urinary bladder.

Authors:  Pradeep Tyagi; Vikas Tyagi; Naoki Yoshimura; Michael Chancellor
Journal:  Indian J Urol       Date:  2010 Jan-Mar

Review 10.  The analgesic potential of cannabinoids.

Authors:  Jaseena Elikkottil; Jaseena Elikottil; Pankaj Gupta; Kalpna Gupta
Journal:  J Opioid Manag       Date:  2009 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.